(Q43599844)

English

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Thierry Poynard

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Christine Katlama

11

object named as

C Katlama

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Y Benhamou

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Bochet

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

V Thibault

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

V Calvez

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M H Fievet

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P Vig

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

C S Gibbs

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

C Brosgart

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J Fry

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Namini

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

358

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

9283

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

718-723

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Progress on the control of hepatitis B infection through immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus infection in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose disorders associated with HIV and its drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905840-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(01)05840-8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43599844&oldid=2101810746"